These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3558412)

  • 1. Inhibition of aromatase cytochrome P-450 by 10-oxirane and 10-thiirane substituted androgens. Implications for the structure of the active site.
    Kellis JT; Childers WE; Robinson CH; Vickery LE
    J Biol Chem; 1987 Mar; 262(9):4421-6. PubMed ID: 3558412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereoselective inhibition of human placental aromatase.
    Childers WE; Shih MJ; Furth PS; Robinson CH
    Steroids; 1987; 50(1-3):121-34. PubMed ID: 3504056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple functions of aromatase and the active site structure; aromatase is the placental estrogen 2-hydroxylase.
    Osawa Y; Higashiyama T; Shimizu Y; Yarborough C
    J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):469-80. PubMed ID: 8476762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of estrogen synthetase (aromatase) by 4-cyclohexylaniline.
    Kellis JT; Vickery LE
    Endocrinology; 1984 Jun; 114(6):2128-37. PubMed ID: 6723577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroperoxides as inactivators of aromatase: 10 beta-hydroperoxy-4-estrene-3,17-dione, crystal structure and inactivation characteristics.
    Covey DF; Hood WF; Beusen DD; Carrell HL
    Biochemistry; 1984 Nov; 23(23):5398-406. PubMed ID: 6509027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The active site of aromatase cytochrome P-450. Differential effects of cyanide provide evidence for proximity of heme-iron and carbon-19 in the enzyme-substrate complex.
    Kellis JT; Vickery LE
    J Biol Chem; 1987 Jun; 262(18):8840-4. PubMed ID: 3597396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different in vitro metabolism of 7 alpha-methyl-19-nortestosterone by human and equine aromatases.
    Moslemi S; Dintinger T; Dehennin L; Silberzahn P; Gaillard JL
    Eur J Biochem; 1993 Jun; 214(2):569-76. PubMed ID: 8513806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Competitive product inhibition of aromatase by natural estrogens.
    Shimizu Y; Yarborough C; Osawa Y
    J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):651-6. PubMed ID: 8476777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzymic aromatization of 6-alkyl-substituted androgens, potent competitive and mechanism-based inhibitors of aromatase.
    Numazawa M; Yoshimura A; Oshibe M
    Biochem J; 1998 Jan; 329 ( Pt 1)(Pt 1):151-6. PubMed ID: 9405288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological characterization of A-ring steroids.
    Johnston JO; Wright CL; Burkhart JP; Peet NP
    J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):623-31. PubMed ID: 8476773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of aromatase cytochrome P-450 (estrogen synthetase) by derivatives of alpha-naphthoflavone.
    Kellis JT; Nesnow S; Vickery LE
    Biochem Pharmacol; 1986 Sep; 35(17):2887-91. PubMed ID: 3741479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of thiol-containing androgens with human placental aromatase.
    Bednarski PJ; Nelson SD
    J Med Chem; 1989 Jan; 32(1):203-13. PubMed ID: 2909733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. R 76713 and enantiomers: selective, nonsteroidal inhibitors of the cytochrome P450-dependent oestrogen synthesis.
    Vanden Bossche H; Willemsens G; Roels I; Bellens D; Moereels H; Coene MC; Le Jeune L; Lauwers W; Janssen PA
    Biochem Pharmacol; 1990 Oct; 40(8):1707-18. PubMed ID: 2242008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human placental estrogen synthetase (aromatase). Effect of environment on the kinetics of protein-protein and substrate-protein interactions and the production of 19-oxygenated androgen intermediates in the purified reconstituted cytochrome P450 enzyme system.
    Sethumadhavan K; Bellino FL
    J Steroid Biochem Mol Biol; 1991 Sep; 39(3):381-94. PubMed ID: 1911429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steroidal inhibitors as chemical probes of the active site of aromatase.
    Brueggemeir RW; Moh PP; Ebrahimian S; Darby MV
    J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):357-65. PubMed ID: 8476749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substrate specificity of the placental microsomal aromatase.
    Gibb W; Lavoie JC
    Steroids; 1980 Nov; 36(5):507-19. PubMed ID: 7456098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The aromatase active site: the C-6 "front" side of the androgen molecule is required for binding.
    Tan L; Rousseau P
    Biochem Biophys Res Commun; 1987 Sep; 147(3):1259-67. PubMed ID: 3663216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 10 beta-propynyl-substituted steroids. Mechanism-based enzyme-activated irreversible inhibitors of estrogen biosynthesis.
    Covey DF; Hood WF; Parikh VD
    J Biol Chem; 1981 Feb; 256(3):1076-9. PubMed ID: 7451489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of human placental aromatase by novel homologated 19-oxiranyl and 19-thiiranyl steroids.
    Childers WE; Silverton JV; Kellis JT; Vickery LE; Robinson CH
    J Med Chem; 1991 Apr; 34(4):1344-9. PubMed ID: 2016709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of human placental aromatase in a perfusion model. Comparison with kinetic, cell-free experiments.
    Klein H; Bartsch W; Niemand A; Stürenburg HJ; Voigt KD
    J Steroid Biochem; 1988 Feb; 29(2):161-9. PubMed ID: 3347056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.